Featured Research

from universities, journals, and other organizations

Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests

Date:
January 21, 2010
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging to help improve the information seen on the images rarely occur, according to a study.

Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology.

Since approval of the first gadolinium-based contrast agent the use of contrast agents for MRI has been evolving. "These agents are useful in the diagnosis of several diseases and conditions and are considered generally safe in clinical practice," said Hani H. Abujudeh, MD, lead author of the study. "However the association between the use of gadolinium-based agents and nephrogenic systemic fibrosis (NSF) has sparked controversy over the years," said Abujudeh.

NSF is a potentially lethal systemic disease that has raised the concern over the use of gadolinium-based contrast agents for imaging of patients with underlying renal impairment. "When prescribing gadolinium-based contrast agents, radiologists need to consider not only the risk of NSF but also the risk of acute adverse reactions," he said.

The study, performed at Massachusetts General Hospital and Harvard Medical School, included a total of 32,659 gadolinium-based contrast injections for MRI examinations. "A total of 51 acute adverse reactions occurred in 50 patients, accounting for 0.16 percent of all administrations," said Abujudeh. The majority of the reactions that did occur were mild including nausea, vomiting, headache, and dizziness. However six moderate and two severe reactions did occur.

"In our study, acute adverse reactions were rare. However it is still important that radiologists and patients be aware of the risks associated with the use of gadolinium-based contrast agents, especially those associated with NSF," said Abujudeh.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American College of Radiology / American Roentgen Ray Society. "Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests." ScienceDaily. ScienceDaily, 21 January 2010. <www.sciencedaily.com/releases/2010/01/100121135710.htm>.
American College of Radiology / American Roentgen Ray Society. (2010, January 21). Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2010/01/100121135710.htm
American College of Radiology / American Roentgen Ray Society. "Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/01/100121135710.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins